Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Biomarker-based early cancer detection: is it achievable?

Literature DB >> 22089449

Biomarker-based early cancer detection: is it achievable?

William D Hazelton¹, E Georg Luebeck.

Abstract

A new mathematical model evaluates the power of blood-based biomarkers for early cancer detection.

Entities: Disease Gene Species

Mesh：

Substances：
Biomarkers, Tumor

Year: 2011 PMID： 22089449 PMCID： PMC3749303 DOI： 10.1126/scitranslmed.3003272

Source DB: PubMed Journal: Sci Transl Med ISSN： 1946-6234 Impact factor: 17.956

9 in total

Review 1. Phases of biomarker development for early detection of cancer.

Authors: M S Pepe; R Etzioni; Z Feng; J D Potter; M L Thompson; M Thornquist; M Winget; Y Yasui
Journal: J Natl Cancer Inst Date: 2001-07-18 Impact factor: 13.506

2. Early detection of ovarian cancer.

Authors: Partha M Das; Robert C Bast
Journal: Biomark Med Date: 2008-06 Impact factor: 2.851

3. Re: Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.

Authors: Patrick C Walsh
Journal: J Urol Date: 2012-08-15 Impact factor: 7.450

4. Mathematical model identifies blood biomarker-based early cancer detection strategies and limitations.

Authors: Sharon S Hori; Sanjiv S Gambhir
Journal: Sci Transl Med Date: 2011-11-16 Impact factor: 17.956

5. Lung cancer signatures in plasma based on proteome profiling of mouse tumor models.

Authors: Ayumu Taguchi; Katerina Politi; Sharon J Pitteri; William W Lockwood; Vitor M Faça; Karen Kelly-Spratt; Chee-Hong Wong; Qing Zhang; Alice Chin; Kwon-Sik Park; Gary Goodman; Adi F Gazdar; Julien Sage; Daniela M Dinulescu; Raju Kucherlapati; Ronald A Depinho; Christopher J Kemp; Harold E Varmus; Samir M Hanash
Journal: Cancer Cell Date: 2011-09-13 Impact factor: 31.743

6. Distant metastasis occurs late during the genetic evolution of pancreatic cancer.

Authors: Shinichi Yachida; Siân Jones; Ivana Bozic; Tibor Antal; Rebecca Leary; Baojin Fu; Mihoko Kamiyama; Ralph H Hruban; James R Eshleman; Martin A Nowak; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; Christine A Iacobuzio-Donahue
Journal: Nature Date: 2010-10-28 Impact factor: 49.962

7. Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries.

Authors: Stacia K Wyman; Rachael K Parkin; Patrick S Mitchell; Brian R Fritz; Kathy O'Briant; Andrew K Godwin; Nicole Urban; Charles W Drescher; Beatrice S Knudsen; Muneesh Tewari
Journal: PLoS One Date: 2009-04-23 Impact factor: 3.240

8. The preclinical natural history of serous ovarian cancer: defining the target for early detection.

Authors: Patrick O Brown; Chana Palmer
Journal: PLoS Med Date: 2009-07-28 Impact factor: 11.069

9. Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study.

Authors: Garnet L Anderson; Martin McIntosh; Lieling Wu; Matt Barnett; Gary Goodman; Jason D Thorpe; Lindsay Bergan; Mark D Thornquist; Nathalie Scholler; Nam Kim; Kathy O'Briant; Charles Drescher; Nicole Urban
Journal: J Natl Cancer Inst Date: 2009-12-30 Impact factor: 13.506

9 in total

Review 8. On the need for the development of a cancer early detection, diagnostic, prognosis, and treatment response system.

Authors: Tobore Onojighofia Tobore
Journal: Future Sci OA Date: 2019-11-29

9. CA 19-9 Pancreatic Tumor Marker Fluorescence Immunosensing Detection via Immobilized Carbon Quantum Dots Conjugated Gold Nanocomposite.

Authors: Nawal Ahmad Alarfaj; Maha Farouk El-Tohamy; Hesham Farouk Oraby
Journal: Int J Mol Sci Date: 2018-04-11 Impact factor: 5.923

9 in total

Biomarker-based early cancer detection: is it achievable?

Review 1. Phases of biomarker development for early detection of cancer.

2. Early detection of ovarian cancer.

3. Re: Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.

4. Mathematical model identifies blood biomarker-based early cancer detection strategies and limitations.

5. Lung cancer signatures in plasma based on proteome profiling of mouse tumor models.

6. Distant metastasis occurs late during the genetic evolution of pancreatic cancer.

7. Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries.

8. The preclinical natural history of serous ovarian cancer: defining the target for early detection.

9. Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study.

1. To Assist Oncologists: An Efficient Machine Learning-Based Approach for Anti-Cancer Peptides Classification.

2. Pancreatic carcinoma, pancreatitis, and healthy controls: metabolite models in a three-class diagnostic dilemma.

3. A Model-Based Personalized Cancer Screening Strategy for Detecting Early-Stage Tumors Using Blood-Borne Biomarkers.

4. Modeling EV Kinetics for Use in Early Cancer Detection.

5. High throughput immunosenor based on multi-label strategy and a novel array electrode.

6. Predicting disease progression from short biomarker series using expert advice algorithm.

7. Label-Free Telomerase Activity Detection via Electrochemical Impedance Spectroscopy.

Review 8. On the need for the development of a cancer early detection, diagnostic, prognosis, and treatment response system.

9. CA 19-9 Pancreatic Tumor Marker Fluorescence Immunosensing Detection via Immobilized Carbon Quantum Dots Conjugated Gold Nanocomposite.